Serum microRNA expression patterns that predict early treatment failure in prostate cancer patients. - Wikidata - wikimedia - TriplyDB

Serum microRNA expression patterns that predict early treatment failure in prostate cancer patients.

Serum microRNA expression patterns that predict early treatment failure in prostate cancer patients.

http://www.wikidata.org/entity/Q37718420

about

Extracellular MicroRNA in liquid biopsy: applicability in cancer diagnosis and prevention The microRNA-183 cluster: the family that plays together stays together Elevated serum microRNA levels associate with absence of high-grade prostate cancer in a retrospective cohort Vitamin D and the RNA transcriptome: more than mRNA regulation.miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression MicroRNA-195 suppresses tumor cell proliferation and metastasis by directly targeting BCOX1 in prostate carcinoma.Vitamin D receptor and RXR in the post-genomic era.VDR regulation of microRNA differs across prostate cell models suggesting extremely flexible control of transcription Abnormal serum microRNA profiles in tuberous sclerosis are normalized during treatment with everolimus: possible clinical implications.Dual-timing PSA as a biomarker for patients with salvage intensity modulated radiation therapy for biochemical failure after radical prostatectomy The Genomic Impact of DNA CpG Methylation on Gene Expression; Relationships in Prostate Cancer Epigenetic modifications in prostate cancer.Epigenetic biomarkers in the blood of patients with urological malignancies.Prognostic and predictive miRNA biomarkers in bladder, kidney and prostate cancer: Where do we stand in biomarker development?MicroRNA-103 suppresses tumor cell proliferation by targeting PDCD10 in prostate cancer.miRNAs as drivers of TMPRSS2-ERG negative prostate tumors in African American men.The utility of urine-circulating miRNAs for detection of prostate cancer.Targeting MicroRNAs in Prostate Cancer Radiotherapy.A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease.The regulatory role of miRNAs on VDR in breast cancer.Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review)

P2860

Q26742027-F1A41C1F-F64D-43B7-BDA2-368BD1AE2BAB Q28080473-ED91545F-0087-46C3-9EEA-380F3D8B5EE9 Q28546311-3E33EB78-42DE-4849-BFFF-6BF3C150DBBF Q33646923-8D6B06A8-12C7-4EC6-AEE2-D82C45CA4BB5 Q35742473-D78D4BFB-DA11-41FB-998E-A2308A13F4D4 Q36025254-441285BB-19F3-4054-9784-239F461BD92E Q36071737-85C45C53-14CD-46F1-AE09-D5EF88402A89 Q36216675-E8008F4B-0136-429F-B2E8-5DFEAA3FC6F4 Q37294665-F14BF0FA-39BE-4709-ACD9-E943C8E25EB5 Q37536842-FEB396A4-01BD-44F5-8732-CC99274FBE8B Q37729422-56D3DF7A-8E19-4066-A729-8E78D040F01D Q38261747-75B0533B-FA9D-4FC0-90B7-32F53C3E784E Q38365422-ABFF2843-77F0-4DFA-9EC4-8EAB72B9F797 Q38667456-34733D3F-DE36-43AB-9F23-8C5F1C4753CC Q38803287-9470AC4F-AA4D-443E-A012-381A42637696 Q39214638-8761A4E4-9B13-4605-B211-543E44EF419D Q41095956-4FC8B95D-DC8A-4031-A929-6C38CA2BB679 Q41239908-7AF95CB9-26FD-4A93-8DCA-BA8FCE925B30 Q47596091-EC192869-D3A5-47E0-B6A4-7D0DD3791CD7 Q48300428-06C48BB7-B159-41EC-9F14-E01495EBF357 Q58799160-3268C0B7-B09D-44D9-A3F4-379AFE1E69E9

P2860

Serum microRNA expression patterns that predict early treatment failure in prostate cancer patients.

http://www.wikidata.org/entity/Q37718420

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Serum microRNA expression patt ...... e in prostate cancer patients.

@en

Serum microRNA expression patt ...... e in prostate cancer patients.

@nl

type

label

Serum microRNA expression patt ...... e in prostate cancer patients.

@en

Serum microRNA expression patt ...... e in prostate cancer patients.

@nl

prefLabel

Serum microRNA expression patt ...... e in prostate cancer patients.

@en

Serum microRNA expression patt ...... e in prostate cancer patients.

@nl

P1433

Q37718420-9212D55A-0322-45B3-99F7-F4444320E90B

P1476

Q37718420-11B75FC7-DC38-4942-AEEE-DCFEF75C3C73

P2093

Q37718420-0EF4ED99-3EA7-4996-970B-11B7F1156889

Q37718420-0EF6C681-AD71-43C5-907B-B868131F39CF

Q37718420-1E304768-60AD-4D9B-B81D-E9EB9E3E6A08

Q37718420-21523135-7DAD-4297-AB62-72372649E885

Q37718420-26F8B989-5575-41D0-A707-8FE106417A1A

Q37718420-32DA019D-A6DF-4E0E-8A73-86E0E3ACC01A

Q37718420-5B55902D-13D1-4AFE-BFCD-51683F2F07A2

Q37718420-70F803D2-0E4F-4D98-B4DA-6969F3FF7177

Q37718420-B2B112F3-924A-447F-9146-5DDAC8140ABC

Q37718420-D6879454-37D7-45E1-8B2D-0C39271B638D

P2860

Q37718420-01C3D732-C0D1-4C0B-8479-38FA77688F12

Q37718420-03E9CFD6-E5C8-49C3-851F-B817FD95687E

Q37718420-0550879C-803D-412B-AC0E-E39A923DA19D

Q37718420-0AAF5C7F-241E-4239-8963-B2BA6AE6351A

Q37718420-0D0C8A7B-FEFF-4461-94B4-E961B03D1268

Q37718420-0D3B218B-CEEE-47F4-9E73-13FC25E0F906

Q37718420-0F1F80B0-7320-4C01-B5EC-F05723438058

Q37718420-1274BCD0-46C4-4E23-8432-9FAA0FE35BA6

Q37718420-140BC7AB-C7A7-400C-B17B-F57AA65959F2

Q37718420-18E49599-BE79-403A-939A-56925258BE82

P304

Q37718420-05284C62-F793-41C0-A8B1-1EAEA3A5D0C0

P31

Q37718420-61643E1F-94E8-455A-A1F5-17FFD23ECB61

P356

Q37718420-740E1524-560A-4430-97B7-F41259D1C6FA

P407

Q37718420-323064FA-336A-42B8-ACFA-8D5DE35D1D3D

P433

Q37718420-0508B6FA-D35A-4DF7-9274-F59567EDE70D

P478

Q37718420-9E411258-A683-4AF9-B787-D34671B948EA

P50

Q37718420-86174A69-08A1-45A5-A0E0-0D2FA1CDF6CD

P577

Q37718420-B2BA0ACB-DED3-4DCA-A771-FB9613FB524D

P5875

Q37718420-384B5A1C-D7DD-4563-AFAC-413F6F4396F1

P698

Q37718420-1F39F034-0B11-4755-867D-4651599A0A0F

P921

Q37718420-C8F554F6-5F5F-4CE4-B197-42011B9F0A64

P932

Q37718420-C8C938E8-E64E-4224-AA17-BDA9809F8BCE

P356

ONCOTARGET.1776

P1433

P1476

Serum microRNA expression patt ...... e in prostate cancer patients.

@en

P2093

Candace S Johnson

http://www.w3.org/2001/XMLSchema#string

Carl D Morrison

http://www.w3.org/2001/XMLSchema#string

Donald L Trump

http://www.w3.org/2001/XMLSchema#string

Lara E Sucheston-Campbell

http://www.w3.org/2001/XMLSchema#string

Leah Preus

http://www.w3.org/2001/XMLSchema#string

Li Yan

http://www.w3.org/2001/XMLSchema#string

Manish Kohli

http://www.w3.org/2001/XMLSchema#string

Mary Nesline

http://www.w3.org/2001/XMLSchema#string

Moray J Campbell

http://www.w3.org/2001/XMLSchema#string

Prashant K Singh

http://www.w3.org/2001/XMLSchema#string

P2860

The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice

A microRNA expression signature of human solid tumors defines cancer gene targets

Mortality results from a randomized prostate-cancer screening trial

Concurrent suppression of integrin alpha5, radixin, and RhoA phenocopies the effects of miR-31 on metastasis

Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers

MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer

MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1

Circulating microRNAs as stable blood-based markers for cancer detection.

The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines

Circulating microRNAs: macro-utility as markers of prostate cancer?

P304

824-840

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.1776

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260445760

http://www.w3.org/2001/XMLSchema#string

P698

24583788

http://www.w3.org/2001/XMLSchema#string

P921

microRNA expression

P932

3996656

http://www.w3.org/2001/XMLSchema#string